visiongain Announces - 3rd Annual Pricing, Reimbursement & Parallel Trade: In the Global and Emerging Markets 2005 – B2B Conferences

Attend the visiongain’s b2b conference: 3rd Annual Pricing, Reimbursement & Parallel Trade: In the Global and Emerging Markets 2005. At this conference, you will hear novel strategies in P&R on national, global and markets levels: regional case studies from top players in the emerging markets, Europe and the US.

London, UK (PRWEB) March 21, 2005

Pricing, Reimbursement & Parallel Trade 2005 will take place on May 25th & 26th in London. The conference will begin May 25th with opening remarks from the conference chairman, Christopher Teale from Allergan.

The 3rd Annual Pricing, Reimbursement and Parallel Trade 2005 will focus on the current trends and update you on issues surrounding P&R, with a special scope on the latest parallel trade developments. In the light of new technologies being developed, pharmaceutical companies are constantly looking for ways to improve their products' competitiveness in the parallel trading grounds. A unique case study by representatives from Pfizer will address the company's latest proposal to implement the new RFID technology in all their products, to facilitate parallel trade in a more secured environment and to avoid counterfeiting in developing countries.

The variations in P&R policies between Europe and North America have already produced a huge gap, leading to a range of controversial issues. This event will explore the pricing and reimbursement environments in Albania, Bulgaria, Croatia, Macedonian, Siberia, Montenegro and Turkey. Discussions of P&R case studies in Germany, Italy, Spain, Ireland will also be examined. With the enlarged Europe and the rising Asian markets, discover how best to manipulate systems to develop the most cost-effective P&R strategy. Find out how can you benefit from market variations and succeed in the evolving parallel trading grounds.

Companies and organisations participating in the conference program:

  • William Haddad, Chairman / CEO, Biogenerics & Active Volunteer, Cipla
  • Julian Mount and Martin Sweeney, Senior Director of European Trade and European External Affairs Manager, Pfizer
  • Dr. Paul Langley, Manager, Health Economic, 3M and Adjunct Professor, College of Pharmacy, University of Minnesota
  • Jie Shen, Head, Pricing, Health Outcome, Access & Key Account Management, Eli Lilly
  • Grant Maclaine, Head, Reimbursement & TA Metabolic, Global Health Economics & Outcomes Research, Bayer
  • Tomasz Dzitko, Director, Delfarma
  • Oliver Schwerdt, Pricing Policy and Controlling, Region Europe, Schering AG
  • Kevin Loth, Director, European Public Affairs, Novartis
  • Chris Teale, Director Health Economics, Pricing, Reimbursment & Product Access, Allergan
  • Dr. Boyan Doganov, Director, International Projects, The International Health Care & Health Insurance Research Institute
  • Dr. Silvio Garratini, Director, Mario Negri Institute
  • Michael Barry, Clinical Director, National Centre for Pharmacoeconomics, St James Hospital

Complementing this conference, is a pre-conference interactive workshop consisting of two stimulating sessions (Tuesday 24th May 2005) entitled: Assessing the Pricing Potential By a Pricing Matrix Model which will be led by: Mark Nuijten, VP, Business Development & Senior Research Scientist, MedTap

Explore Novel Pricing & Reimbursement Strategies in Europe that will be led by: Klaus Hilleke, Senior Partner, Simon-Kuchers & Partner

For more information about this event, please visit:

http://www.b2b-conferences.com/Pharmaceuticals/168/3rd-Annual-Pricing,-Reimbursement-and-Parallel-Trade-2005.html

About B2B Conferences:

B2B Conferences is one of Europe’s fastest growing media companies today, basing its knowledge on the raft of management reports and industry news letter that the parent company produces each year. B2B Conferences has built up a solid reputation for putting together high quality business to business event workshops aimed at the corporate community.

These events are unique in that B2B operates on a wholly independent basis, therefore producing conferences that are timely, targeted and at time controversial, giving delegates, speakers and sponsors alike, the opportunity to get a totally unbiased view of their industry.

For additional information contact:

Senh Ip

Corporate communications

Tel: +44 (0) 20 8767 6711

Fax: +44 (0) 20 8767 5001

Email: Senh.ip@visiongain.com

For more information visiongain, please visit http://www.visiongain.com

Corporate tables and sponsorship/exhibitor opportunities are still available; please call the hotline or email Andrew.oliver@visiongain.com for more information.

###


Contact